Clinical Trials Insight: 700049934
Phase of Trial: Phase III
Latest Information Update: 04 Mar 2010
At a glance
- Drugs Interferon alpha (Primary)
- Indications Influenza virus infections
- Focus Registrational; Therapeutic Use
- Sponsors Intas Pharmaceuticals
- 04 Mar 2010 The trial is expected to start at the end of March 2010, as reported by Amarillo Biosciences.
- 13 Oct 2009 New trial record.